Abstract
The Brown University Geriatric Psychopharmacology UpdateVolume 10, Issue 6 p. 1-8 Table of Contents First published: 17 May 2006 https://doi.org/10.1002/gpu.20021AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract New Study Investigates Donepezil for Severe Alzheimer's Disease Advocates Pleased with FDA Committee Review of ADHD Medications Hepatitis Linked to Low-Dose Venlafaxine Venlafaxine IR, Fluoxetine and Placebo Effective in Reducing Depression in Elderly Selegiline May Slow Progression of Parkinson's Disease ADHD Drugs for which Serious Adverse Events Were Reported to the FDA Between 1 January 1999 and 31 December 2003 Medroxyprogesterone for Inappropriate Sexual Behavior in Male Dementia Patients 50 mg Topiramate Tablets Approval: Naltrexone Injectable Suspension (Vivitrol) Volume10, Issue6June 2006Pages 1-8 RelatedInformation
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
